Evalon
eimeria acervulina, strain 003 / eimeria brunetti, strain 034 / eimeria maxima, strain 013 / eimeria necatrix, strain 033 / eimeria tenella, strain 004
Table of contents
Overview
This is a summary of the European public assessment report (EPAR) for Evalon.It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Evalon.
For practical information about using Evalon, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Authorisation details
Product details | |
---|---|
Name |
Evalon
|
Agency product number |
EMEA/V/C/004013
|
Active substance |
vaccine against coccidiosis in chickens
|
International non-proprietary name (INN) or common name |
|
Species |
Chicken
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI01AN01
|
Publication details | |
---|---|
Marketing-authorisation holder |
Laboratorios Hipra, S.A.
|
Revision |
2
|
Date of issue of marketing authorisation valid throughout the European Union |
18/04/2016
|
Contact address |
Avda. La Selva 135 |
Product information
12/02/2021 Evalon - EMEA/V/C/004013 - R/0003
Contents
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Pharmacotherapeutic group
-
Live parasitic vaccines
-
Immunologicals for aves
Therapeutic indication
For active immunisation of chicks from 1 day of age to reduce clinical signs (diarrhoea), intestinal lesions and oocysts output associated with coccidiosis caused by Eimeria acervulina, Eimeria brunetti, Eimeria maxima, Eimeria necatrix and Eimeria tenella.